TACE-assisted multi-image guided radiofrequency ablation for the treatment of single hepatocellular carcinoma ≤ 5 cm: a retrospective study

TACE-assisted multi-image guided radiofrequency ablation for the treatment of single hepatocellular carcinoma ≤ 5 cm: a retrospective study

Background/ObjectiveTreatment of hepatocellular carcinoma (HCC) with ablation alone often results in high rates of recurrence and metastasis, reaching up to 25.9% within two years. Therefore, this study aimed to examine the efficacy and safety of transarterial chemoembolization (TACE)-assisted multi...

Full description

Bibliographic Details
Main Authors:	Yong Xie, Tianshi Lyu, Li Song, Xiaoqiang Tong, Jian Wang, Yinghua Zou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma (HCC) transarterial chemoembolization (TACE) radiofrequency ablation (RFA) local tumor progression (LTP) overall survival (OS) complication
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1347675/full

Similar Items

Common interventional techniques (single versus combined) in management of hepatocellular carcinoma
by: Mostafa M. Shakweer, et al.
Published: (2016-12-01)

Combined versus single interventional therapies in treatment of hepatic malignant tumors
by: Gihan Hassan Gamal, et al.
Published: (2014-03-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
by: Hongye Wang, et al.
Published: (2023-06-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
by: Rui Chen, et al.
Published: (2023-02-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Downstaging and laparoscopic hepatectomy plus intraoperative radiofrequency ablation for the treatment of initially unresectable multifocal hepatocellular carcinomas
by: Jianjun Wang, et al.
Published: (2024-01-01)

A systematic review and meta-analysis of the comparison of laparoscopic radiofrequency ablation to percutaneous radiofrequency ablation for hepatocellular carcinoma
by: Ya-Qiong Wang, et al.
Published: (2025-03-01)

Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study
by: Yang C, et al.
Published: (2022-07-01)

Optimizing outcomes in HCC: Comment on “optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis” by Jiang et al.
by: Alessandro Rizzo
Published: (2021-12-01)

Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
by: Zhao Wu, et al.
Published: (2023-04-01)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
by: Tae Hoon Kim, et al.
Published: (2021-09-01)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
by: Bufu Tang, et al.
Published: (2023-05-01)

Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real‐world study
by: Jianwei Liu, et al.
Published: (2024-06-01)

Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Published: (2014-09-01)

Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis
by: Peng Guo, et al.
Published: (2024-04-01)

Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
by: Ah Ran Kim, et al.
Published: (2019-03-01)

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
by: Yuan H, et al.
Published: (2018-11-01)

Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
by: Liangliang Yan, et al.
Published: (2021-04-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
by: V. V. Breder, et al.
Published: (2018-07-01)

Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns
by: Yong Xie, et al.
Published: (2024-05-01)

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients
by: Jing-huan Li, et al.
Published: (2021-08-01)

Combined versus single locoregional therapy in the treatment of unresectable hepatocellular carcinoma
by: Moustafa H.M. Othman, et al.
Published: (2014-06-01)

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis
by: Yuan Dan, et al.
Published: (2022-07-01)

Thermal Injury to the Subhepatic Appendix Following Percutaneous Ultrasound-Guided Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report
by: Eun Ju Yoon, et al.
Published: (2023-10-01)

Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
by: Hongfa Sun, et al.
Published: (2023-03-01)

The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion
by: Zhenwei Peng, et al.
Published: (2022-12-01)

Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization
by: CHENG Chienshan, ZHANG Tao, WU Junwei, GAO Huifeng, CHEN Jingxian, MENG Zhiqiang
Published: (2024-07-01)

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
by: Hyo-Cheol Kim
Published: (2023-10-01)

Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy
by: Marwa Ahmed Sakr, et al.
Published: (2021-03-01)

A multicenter, randomized, parallel-controlled clinical trial protocol to evaluate the safety and efficacy of irreversible electroporation compared with radiofrequency ablation for the treatment of small hepatocellular carcinoma
by: Chao Cheng, et al.
Published: (2024-12-01)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
by: Amira Isaac, et al.
Published: (2021-11-01)

FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE
by: Apichat Kaewdech, et al.
Published: (2023-05-01)